missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SLC25A17 Polyclonal Antibody
Rabbit Polyclonal Antibody
Marque: Invitrogen™ PA526180
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
SLC25A17 Polyclonal Antibody for Western Blot, Flow
This protein encodes a selenoprotein, which contains a selenocysteine (Sec) residue at its active site. The selenocysteine is encoded by the UGA codon that normally signals translation termination. The 3' UTR of selenoprotein genes have a common stem-loop structure, the sec insertion sequence (SECIS), that is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Studies suggest that this protein may regulate cytokine production, and thus play a key role in the control of the inflammatory response.
Spécification
| SLC25A17 | |
| Polyclonal | |
| Unconjugated | |
| SLC25A17 | |
| 34 kDa peroxisomal membrane protein; 34kDa; 47kDa; peroxisomal integral membrane protein 47; peroxisomal membrane protein PMP34; peroxisomal membrane protein, 34 kDa; Pmp34; Pmp35; Pmp47; SLC25A17; solute carrier family 25 (mitochondrial carrier, peroxisomal membrane protein), member 17; solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17; solute carrier family 25 member 17; solute carrier family 25, member 17 | |
| Rabbit | |
| Antigen affinity chromatography, Protein A | |
| RUO | |
| 10478, 20524 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Flow Cytometry, Western Blot | |
| 0.35 mg/mL | |
| PBS with 0.09% sodium azide; pH 7.4 | |
| O43808, O70579 | |
| SLC25A17 | |
| KLH conjugated synthetic peptide between 17-44 amino acids from the N-terminal region of human SLC25A17. | |
| 400 μL | |
| Primary | |
| Human, Mouse | |
| Antibody | |
| IgG |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu